About Type II (Non-insulin Dependent) Diabetes Mellitus --------------------------------------------------------------------------- Type 2 Diabetes Type 2 diabetes, also known as non-insulin-dependent diabetes mellitus (NIDDM), is a serious disease that requires effective control. Type 2 diabetes is associated with increased morbidity and mortality, mainly from cardiovascular diseases, when compared with the general population 1,2 (Table 1). Type 2 diabetes is not a mild form of Type 1 diabetes (insulin- dependent diabetes mellitus, IDDM) and can also lead to impaired vision, renal function and nerve damage. Unlike Type 1 diabetes, the insidious nature of Type 2 diabetes means that many patients have only mild symptoms or, indeed, no symptoms at all. Consequently, patients often do not present until cardiovascular and other end organ damage has occurred 2. ----------------------------------------------------------------- Complications Associated With Type 2 Diabetes 1 TABLE 1. Prevalence in Prevalence Ratio Type 2 Diabetes between (%) Type 2 Diabetes and the General Population Mortality - 2-3 Ischaemic Heart Disease 50 2 Peripheral Vascular Disease 50 2-6 Chronic Foot Ulcers 8 4 Amputations 2 20 Stroke 3 4-10 Hypertension 45 2 Hyperlipidaemia 45 4-5 Reduced Visual Acuity: - All ages 11 - - > 60 years of age 38 2 Clinical Nephropathy 8 5 Urinary Tract Infections: Men 6 2 Women 30 2 Polyneuropathy 6-50 - Autonomic Neuropathy 40 2 Evidence is mounting that if Type 2 diabetes is recognized earlier and treated more effectively, then the progression of complications can be slowed and the morbidity and mortality associated with this condition reduced. Early and more effective treatment can be achieved through early diagnosis namely, screening by measuring blood glucose levels (Figure 1) in patients at risk, or those presenting with symptoms associated with diabetes 3,4. ---------------------------------------------------------------------- Prevalence It has been estimated that the overall prevalence of Type 2 diabetes in Caucasian populations is approximately 2%. However, the prevalence of Type 2 diabetes increases with age 5: + 4% of the population above 60 years of age + 10% of the population above 70 years of age. Furthermore, it has been estimated that approximately another 2% of the total population currently have undiagnosed Type 2 diabetes. Copyright © Novo Nordisk Pharmaceuticals Pty Ltd, 1995 ® Novocare is a Registered Trademark of Novo Nordisk A/S